{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:01:52Z","timestamp":1785528112144,"version":"3.56.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04845-y","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:30:26Z","timestamp":1779975026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CCNA2, MAD2L1, AURKA, and PTTG1 promote proliferation and migration in hepatocellular carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Wang","family":"Jinli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Shiping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"1","key":"4845_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12859-023-05220-4","volume":"24","author":"W-X Yang","year":"2023","unstructured":"Yang W-X, et al. Development and validation of a coagulation-related genes prognostic model for hepatocellular carcinoma. BMC Bioinformatics. 2023;24(1):89.","journal-title":"BMC Bioinformatics"},{"key":"4845_CR2","doi-asserted-by":"crossref","unstructured":"Huang R, et al. PWP1 is overexpressed in hepatocellular carcinoma and facilitates liver cancer cell proliferation. Heliyon. 2024;10(11):e32409.","DOI":"10.1016\/j.heliyon.2024.e32409"},{"key":"4845_CR3","unstructured":"Liu Q, et al. Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for hepatocellular carcinoma. Hepatology. 2024;81(4):101097."},{"issue":"9","key":"4845_CR4","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.7150\/ijms.45256","volume":"17","author":"M-R Wang","year":"2020","unstructured":"Wang M-R, et al. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK\/ERK pathway. Int J Med Sci. 2020;17(9):1224.","journal-title":"Int J Med Sci"},{"issue":"4","key":"4845_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.patbio.2010.01.005","volume":"58","author":"M Kew","year":"2010","unstructured":"Kew M. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris). 2010;58(4):273\u20137.","journal-title":"Pathol Biol (Paris)"},{"issue":"2","key":"4845_CR6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/HEP.0000000000000657","volume":"80","author":"A-L Scherr","year":"2024","unstructured":"Scherr A-L, et al. Etiology-independent activation of the LT\u03b2-LT\u03b2R-RELB axis drives aggressiveness and predicts poor prognosis in HCC. Hepatology. 2024;80(2):278\u201394.","journal-title":"Hepatology"},{"key":"4845_CR7","doi-asserted-by":"crossref","unstructured":"Dobritoiu R, et al. Vertical Transmission of Hepatitis B and C-Then and Now-A Comprehensive Literature Systematic Review. Viruses. 2025;17(10):1395.","DOI":"10.3390\/v17101395"},{"issue":"6","key":"4845_CR8","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.3390\/ijms25063103","volume":"25","author":"AV Vasileva","year":"2024","unstructured":"Vasileva AV, et al. Super-enhancers and their parts: from prediction efforts to pathognomonic status. Int J Mol Sci. 2024;25(6):3103.","journal-title":"Int J Mol Sci"},{"key":"4845_CR9","doi-asserted-by":"crossref","unstructured":"Giri S, Singh A. Epidemiology of Hepatocellular Carcinoma in India\u2013An Updated Review for 2024. J Clin Experimental Hepatol. 2024;14(6):101447.","DOI":"10.1016\/j.jceh.2024.101447"},{"issue":"6","key":"4845_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/cells12060869","volume":"12","author":"P-S Huang","year":"2023","unstructured":"Huang P-S, et al. Evaluation and application of drug resistance by biomarkers in the clinical treatment of liver cancer. Cells. 2023;12(6):869.","journal-title":"Cells"},{"issue":"20","key":"4845_CR11","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.3390\/cancers15205046","volume":"15","author":"X Chen","year":"2023","unstructured":"Chen X, Liu X, Du S. Unveiling the role of tumor-infiltrating T cells and immunotherapy in hepatocellular carcinoma: a comprehensive review. Cancers. 2023;15(20):5046.","journal-title":"Cancers"},{"key":"4845_CR12","doi-asserted-by":"publisher","first-page":"100424","DOI":"10.1016\/j.ejro.2022.100424","volume":"9","author":"X Tong","year":"2022","unstructured":"Tong X, Li J. Noninvasively predict the micro-vascular invasion and histopathological grade of hepatocellular carcinoma with CT-derived radiomics. Eur J Radiol Open. 2022;9:100424.","journal-title":"Eur J Radiol Open"},{"issue":"9","key":"4845_CR13","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.21037\/tcr-20-1294","volume":"9","author":"PC Sharma","year":"2020","unstructured":"Sharma PC, Gupta A. MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers. Translational cancer Res. 2020;9(9):5798.","journal-title":"Translational cancer Res"},{"issue":"sup2","key":"4845_CR14","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1517\/14728222.2011.650632","volume":"16","author":"LR Corsini","year":"2012","unstructured":"Corsini LR, et al. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Expert Opin Ther Targets. 2012;16(sup2):S103\u20139.","journal-title":"Expert Opin Ther Targets"},{"issue":"5","key":"4845_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/genes15050577","volume":"15","author":"R Khan","year":"2024","unstructured":"Khan R, Pari B, Puszynski K. Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse Cancer Landscapes. Genes. 2024;15(5):577.","journal-title":"Genes"},{"issue":"12","key":"4845_CR16","doi-asserted-by":"publisher","first-page":"16367","DOI":"10.18632\/aging.203162","volume":"13","author":"J Liao","year":"2021","unstructured":"Liao J, et al. High S100A9\u2009+\u2009cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection. Aging. 2021;13(12):16367.","journal-title":"Aging"},{"key":"4845_CR17","doi-asserted-by":"publisher","first-page":"857060","DOI":"10.3389\/fphar.2022.857060","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. Identification of a DNA damage response and repair-related gene-pair signature for prognosis stratification analysis in hepatocellular carcinoma. Front Pharmacol. 2022;13:857060.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4845_CR18","doi-asserted-by":"publisher","first-page":"e3945","DOI":"10.1002\/cbf.3945","volume":"42","author":"SMN Mydin","year":"2024","unstructured":"Mydin SMN. Regulatory role of miRNAs in nasopharyngeal cancer involving PTEN\/PI3K\/AKT, TGF\u03b2\/SMAD, RAS\/MAPK, Wnt\/\u03b2-catenin and pRB\u2010E2F signaling pathways: A review. Cell Biochem Funct. 2024;42(2):e3945.","journal-title":"Cell Biochem Funct"},{"key":"4845_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fonc.2020.00809","volume":"10","author":"S Liu","year":"2020","unstructured":"Liu S, et al. Identification of potential key genes for pathogenesis and prognosis in prostate cancer by integrated analysis of gene expression profiles and the cancer genome atlas. Front Oncol. 2020;10:809.","journal-title":"Front Oncol"},{"issue":"16","key":"4845_CR20","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1093\/cid\/ciaa462","volume":"71","author":"Y Ouyang","year":"2020","unstructured":"Ouyang Y, et al. Downregulated gene expression spectrum and immune responses changed during the disease progression in patients with COVID-19. Clin Infect Dis. 2020;71(16):2052\u201360.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"4845_CR21","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.7150\/ijbs.68179","volume":"18","author":"S Bian","year":"2022","unstructured":"Bian S, et al. Flap endonuclease 1 facilitated hepatocellular carcinoma progression by enhancing USP7\/MDM2-mediated P53 inactivation. Int J Biol Sci. 2022;18(3):1022.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"4845_CR22","doi-asserted-by":"publisher","first-page":"BSR20211577","DOI":"10.1042\/BSR20211577","volume":"41","author":"W El Khoury","year":"2021","unstructured":"El Khoury W, Nasr Z. Deregulation of ribosomal proteins in human cancers. Biosci Rep. 2021;41(12):BSR20211577.","journal-title":"Biosci Rep"},{"key":"4845_CR23","unstructured":"Guerreiro \u00cdCF. Exploring New Therapeutic Targets and Novel Therapies for Resistant Colorectal Cancer Subtypes. Portugal: Universidade NOVA de Lisboa; 2019."},{"key":"4845_CR24","doi-asserted-by":"crossref","unstructured":"Clough E, Barrett T. The Gene Expression Omnibus Database. Methods Mol Biol. 2016;1418:3578\u201395.","DOI":"10.1007\/978-1-4939-3578-9_5"},{"issue":"D1","key":"4845_CR25","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"4845_CR26","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman BT, et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022;50(W1):W216\u201321.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"4845_CR27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, et al. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017;19(8):649\u201358.","journal-title":"Neoplasia"},{"issue":"D1","key":"4845_CR28","doi-asserted-by":"publisher","first-page":"D1334","DOI":"10.1093\/nar\/gkab970","volume":"50","author":"G Tang","year":"2022","unstructured":"Tang G, Cho M, Wang X. OncoDB: an interactive online database for analysis of gene expression and viral infection in cancer. Nucleic Acids Res. 2022;50(D1):D1334\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4845_CR29","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"issue":"7","key":"4845_CR30","doi-asserted-by":"publisher","first-page":"27633","DOI":"10.2196\/27633","volume":"23","author":"A L\u00e1nczky","year":"2021","unstructured":"L\u00e1nczky A, Gy\u0151rffy B. Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation. J Med Internet Res. 2021;23(7):27633.","journal-title":"J Med Internet Res"},{"key":"4845_CR31","doi-asserted-by":"crossref","unstructured":"Liu CJ, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023;24(1):bbac558.","DOI":"10.1093\/bib\/bbac558"},{"issue":"1","key":"4845_CR32","first-page":"9421079","volume":"2019","author":"R Pezzani","year":"2019","unstructured":"Pezzani R, et al. Novel prognostic factors associated with cell cycle control in sporadic medullary thyroid cancer patients. Int J Endocrinol. 2019;2019(1):9421079.","journal-title":"Int J Endocrinol"},{"key":"4845_CR33","doi-asserted-by":"publisher","first-page":"655697","DOI":"10.3389\/fimmu.2021.655697","volume":"12","author":"J Giraud","year":"2021","unstructured":"Giraud J, et al. Hepatocellular carcinoma immune landscape and the potential of immunotherapies. Front Immunol. 2021;12:655697.","journal-title":"Front Immunol"},{"key":"4845_CR34","doi-asserted-by":"publisher","first-page":"108436","DOI":"10.1016\/j.engappai.2024.108436","volume":"133","author":"H Jiang","year":"2024","unstructured":"Jiang H, et al. Deep learning for liver cancer histopathology image analysis: A comprehensive survey. Eng Appl Artif Intell. 2024;133:108436.","journal-title":"Eng Appl Artif Intell"},{"issue":"36","key":"4845_CR35","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.3748\/wjg.v27.i36.6025","volume":"27","author":"E Amponsah-Dacosta","year":"2021","unstructured":"Amponsah-Dacosta E. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030? World J Gastroenterol. 2021;27(36):6025.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"4845_CR36","doi-asserted-by":"publisher","first-page":"554","DOI":"10.21147\/j.issn.1000-9604.2022.06.02","volume":"34","author":"Q Li","year":"2022","unstructured":"Li Q, et al. Burden of liver cancer: From epidemiology to prevention. Chin J Cancer Res. 2022;34(6):554.","journal-title":"Chin J Cancer Res"},{"key":"4845_CR37","doi-asserted-by":"crossref","unstructured":"Chen Q, Ouyang L, Liu Q. Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer. Biomol Biomed. 2024.24(5):1150\u201369.","DOI":"10.17305\/bb.2024.10253"},{"issue":"8","key":"4845_CR38","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.21037\/tcr-22-218","volume":"11","author":"Z Tan","year":"2022","unstructured":"Tan Z, et al. E2F1 as a potential prognostic and therapeutic biomarker by affecting tumor development and immune microenvironment in hepatocellular carcinoma. Translational cancer Res. 2022;11(8):2713.","journal-title":"Translational cancer Res"},{"key":"4845_CR39","doi-asserted-by":"crossref","unstructured":"Czauderna C, et al. Epigenetic modifications precede molecular alterations and drive human hepatocarcinogenesis. JCI insight. 2021;6(17):e146196.","DOI":"10.1172\/jci.insight.146196"},{"issue":"5","key":"4845_CR40","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.7150\/jca.38173","volume":"11","author":"R Yang","year":"2020","unstructured":"Yang R, et al. Weighted gene co-expression network analysis identifies CCNA2 as a treatment target of prostate cancer through inhibiting cell cycle. J Cancer. 2020;11(5):1203.","journal-title":"J Cancer"},{"issue":"1","key":"4845_CR41","doi-asserted-by":"publisher","first-page":"23681","DOI":"10.1038\/s41598-021-03166-2","volume":"11","author":"Z Li","year":"2021","unstructured":"Li Z, et al. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA\/PLK1 pathway. Sci Rep. 2021;11(1):23681.","journal-title":"Sci Rep"},{"issue":"2","key":"4845_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10577-020-09646-x","volume":"29","author":"S Sarkar","year":"2021","unstructured":"Sarkar S, et al. Mitotic checkpoint defects: en route to cancer and drug resistance. Chromosome Res. 2021;29(2):131\u201344.","journal-title":"Chromosome Res"},{"key":"4845_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/bs.ircmb.2016.08.004","volume":"328","author":"G Manic","year":"2017","unstructured":"Manic G, et al. Molecular regulation of the spindle assembly checkpoint by kinases and phosphatases. Int Rev cell Mol biology. 2017;328:105\u201361.","journal-title":"Int Rev cell Mol biology"},{"issue":"2","key":"4845_CR44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.46810\/tdfd.1476374","volume":"13","author":"S Sar\u0131","year":"2024","unstructured":"Sar\u0131 S, \u00d6zsoy ER. Aurora Kinases: Their Role in Cancer and Cellular Processes. T\u00fcrk Do\u011fa ve Fen Dergisi. 2024;13(2):128\u201339.","journal-title":"T\u00fcrk Do\u011fa ve Fen Dergisi"},{"issue":"3","key":"4845_CR45","first-page":"2591","volume":"16","author":"Y Dong","year":"2024","unstructured":"Dong Y, et al. Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures. Aging. 2024;16(3):2591.","journal-title":"Aging"},{"issue":"2","key":"4845_CR46","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3390\/biom10020237","volume":"10","author":"B Deb","year":"2020","unstructured":"Deb B, et al. Bioinformatics analysis of global proteomic and phosphoproteomic data sets revealed activation of NEK2 and AURKA in cancers. Biomolecules. 2020;10(2):237.","journal-title":"Biomolecules"},{"issue":"8","key":"4845_CR47","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/s41589-018-0081-9","volume":"14","author":"HJ Donnella","year":"2018","unstructured":"Donnella HJ, et al. Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer. Nat Chem Biol. 2018;14(8):768\u201377.","journal-title":"Nat Chem Biol"},{"key":"4845_CR48","doi-asserted-by":"crossref","unstructured":"Hu X, Yang F, Mei H. Pituitary tumor transforming gene 1 promotes proliferation and malignant phenotype in osteosarcoma via NF-\u03baB signaling. J Orthop Sci. 2022;29(1):306\u201314 .","DOI":"10.1016\/j.jos.2022.10.020"},{"issue":"2","key":"4845_CR49","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11154-022-09777-y","volume":"24","author":"D Marrero-Rodr\u00edguez","year":"2023","unstructured":"Marrero-Rodr\u00edguez D, et al. The hallmarks of cancer\u2026 in pituitary tumors? Reviews Endocr Metabolic Disorders. 2023;24(2):177\u201390.","journal-title":"Reviews Endocr Metabolic Disorders"},{"key":"4845_CR50","doi-asserted-by":"publisher","first-page":"p1386427","DOI":"10.3389\/fimmu.2024.1386427","volume":"15","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. Identification and validation of tryptophan-related gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma reveals a critical role for PTTG1. Front Immunol. 2024;15:p1386427.","journal-title":"Front Immunol"},{"key":"4845_CR51","first-page":"p1245072","volume":"20191","author":"W-X Yang","year":"2019","unstructured":"Yang W-X, Pan Y-Y, You C-G. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 may be potential therapeutic targets for hepatocellular carcinoma using integrated bioinformatic analysis. Biomed Res Int. 2019;20191:p1245072.","journal-title":"Biomed Res Int"},{"key":"4845_CR52","doi-asserted-by":"crossref","unstructured":"Zhao R, Ning X, Lu H, Xu W, Ma J, Cheng J, Ma R. XTP8 Promotes Ovarian Cancer Progression by Activating AKT\/AMPK\/mTOR Pathway to Regulate EMT. Cell Biochem Biophys. 2024;82(2):945\u201357.","DOI":"10.1007\/s12013-024-01246-4"},{"issue":"4","key":"4845_CR53","doi-asserted-by":"publisher","first-page":"931","DOI":"10.4103\/jcrt.JCRT_536_19","volume":"17","author":"Y Hameed","year":"2021","unstructured":"Hameed Y, Ejaz S. TP53 lacks tetramerization and N-terminal domains due to novel inactivating mutations detected in leukemia patients. J Cancer Res Ther. 2021;17(4):931\u20137.","journal-title":"J Cancer Res Ther"},{"issue":"15","key":"4845_CR54","doi-asserted-by":"publisher","first-page":"16370","DOI":"10.1002\/cam4.6271","volume":"12","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Identification and validation of Birc5 as a novel activated cell cycle program biomarker associated with infiltration of immunosuppressive myeloid-derived suppressor cells in hepatocellular carcinoma. Cancer Med. 2023;12(15):16370\u201385.","journal-title":"Cancer Med"},{"issue":"18","key":"4845_CR55","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.7150\/ijms.49652","volume":"17","author":"C-C Wu","year":"2020","unstructured":"Wu C-C, et al. Gene signatures and prognostic analyses of the Tob\/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients. Int J Med Sci. 2020;17(18):3112.","journal-title":"Int J Med Sci"},{"issue":"22","key":"4845_CR56","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.4161\/cc.7.22.7042","volume":"7","author":"A Veerakumarasivam","year":"2008","unstructured":"Veerakumarasivam A, et al. AURKA overexpression accompanies dysregulation of DNA-damage response genes in invasive urothelial cell carcinoma. Cell Cycle. 2008;7(22):3525\u201333.","journal-title":"Cell Cycle"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04845-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04845-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:16:49Z","timestamp":1785521809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04845-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4845"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04845-y","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"479"}}